DATASETCANCER TYPESUBTYPEENDPOINTCOHORTCONTRIBUTORARRAY TYPEN
GSE5287Bladder cancerOverall SurvivalAarhus (1995-2004)AlsHG-U133An=30
GSE13507Bladder cancerOverall SurvivalCNUHKimHuman-6 v2n=165
GSE13507Bladder cancerTransitional cell carcinoma Disease Specific SurvivalCNUHKimHuman-6 v2n=165
GSE12417-GPL96Blood cancerAMLOverall SurvivalAMLCG (1999-2003)MetzelerHG-U133An=163
GSE12417-GPL97Blood cancerAMLOverall SurvivalAMLCG (1999-2003)MetzelerHG-U133Bn=163
GSE12417-GPL570Blood cancerAMLOverall SurvivalAMLCG (2004)MetzelerHG-U133_Plus_2n=79
GSE5122Blood cancerAMLOverall SurvivalSan DiegoRaponiHG-U133An=58
GSE8970Blood cancerAMLOverall SurvivalSan DiegoRaponiHG-U133An=34
GSE4475Blood cancerB-cell lymphomaOverall SurvivalBerlin (2003-2005)HummelHG-U133An=158
E-TABM-346Blood cancerDLBCLEvent Free SurvivalGELA (1998-2000)JaisHG-U133An=53
E-TABM-346Blood cancerDLBCLOverall SurvivalGELA (1998-2000)JaisHG-U133An=53
GSE16131-GPL96Blood cancerFollicular lymphomaOverall SurvivalNCI (1974-2001)DaveHG-U133An=180
GSE16131-GPL97Blood cancerFollicular lymphomaOverall SurvivalNCI (1974-2001)DaveHG-U133Bn=180
GSE2658Blood cancerMultiple myelomaDisease Specific SurvivalArkansasZhanHG-U133_Plus_2n=559
GSE19615Breast cancerDistant Metastasis Free SurvivalDF/HCCLiHG-U133_Plus_2n=115
GSE3143Breast cancerOverall SurvivalDukeBildHG-U95An=158
GSE7849Breast cancerDisease Free SurvivalDuke (1990-2001)AndersHG-U95An=76
GSE6532-GPL570Breast cancerRecurrence Free SurvivalGUYTLoiHG-U133_Plus_2n=87
GSE6532-GPL570Breast cancerDistant Metastasis Free SurvivalGUYTLoiHG-U133_Plus_2n=87
GSE9195Breast cancerDistant Metastasis Free SurvivalGUYT2LoiHG-U133_Plus_2n=77
GSE9195Breast cancerRecurrence Free SurvivalGUYT2LoiHG-U133_Plus_2n=77
GSE12093Breast cancerDistant Metastasis Free SurvivalIO, NCI, TUM, CCF (1992-2000)ZhangHG-U133An=136
GSE11121Breast cancerDistant Metastasis Free SurvivalMainz (1988-1998)SchmidtHG-U133An=200
GSE1378Breast cancerRecurrence Free SurvivalMGH (1987-2000)MaArcturus 22kn=60
GSE1379Breast cancerRecurrence Free SurvivalMGH (1987-2000)MaArcturus 22kn=60
GSE9893Breast cancerOverall SurvivalMontpellier, Bordeaux, Turin (1989-2001)ChanrionMLRG Human 21K V12.0n=155
GSE2034Breast cancerDistant Metastasis Free SurvivalRotterdam (1980-1995)WangHG-U133An=286
GSE1456-GPL96Breast cancerOverall SurvivalStockholm (1994-1996)PawitanHG-U133An=159
GSE1456-GPL96Breast cancerRecurrence Free SurvivalStockholm (1994-1996)PawitanHG-U133An=159
GSE1456-GPL96Breast cancerDisease Specific SurvivalStockholm (1994-1996)PawitanHG-U133An=159
GSE1456-GPL97Breast cancerOverall SurvivalStockholm (1994-1996)PawitanHG-U133Bn=159
GSE1456-GPL97Breast cancerRecurrence Free SurvivalStockholm (1994-1996)PawitanHG-U133Bn=159
GSE1456-GPL97Breast cancerDisease Specific SurvivalStockholm (1994-1996)PawitanHG-U133Bn=159
GSE7378Breast cancerDisease Free SurvivalUCSFZhouU133AAofAv2n=54
E-TABM-158Breast cancerDistant Metastasis Free SurvivalUCSF, CPMC (1989-1997)ChinHG-U133An=117
E-TABM-158Breast cancerOverall SurvivalUCSF, CPMC (1989-1997)ChinHG-U133An=117
E-TABM-158Breast cancerRecurrence Free SurvivalUCSF, CPMC (1989-1997)ChinHG-U133An=117
E-TABM-158Breast cancerDisease Specific SurvivalUCSF, CPMC (1989-1997)ChinHG-U133An=117
GSE3494-GPL96Breast cancerDisease Specific SurvivalUppsala (1987-1989)MillerHG-U133An=236
GSE3494-GPL97Breast cancerDisease Specific SurvivalUppsala (1987-1989)MillerHG-U133Bn=236
GSE4922-GPL96Breast cancerDisease Free SurvivalUppsala (1987-1989)IvshinaHG-U133An=249
GSE4922-GPL97Breast cancerDisease Free SurvivalUppsala (1987-1989)IvshinaHG-U133Bn=249
GSE2990Breast cancerDistant Metastasis Free SurvivalUppsala, OxfordSotiriouHG-U133An=179
GSE2990Breast cancerRelapse Free SurvivalUppsala, OxfordSotiriouHG-U133An=187
GSE7390Breast cancerDistant Metastasis Free SurvivalUppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)DesmedtHG-U133An=198
GSE7390Breast cancerOverall SurvivalUppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)DesmedtHG-U133An=198
GSE7390Breast cancerRecurrence Free SurvivalUppsala, Oxford, Stockholm, IGR, GUYT, CRH (1980-1998)DesmedtHG-U133An=198
GSE12945Colorectal cancerOverall SurvivalBerlinStaubHG-U133An=62
GSE17536Colorectal cancerOverall SurvivalMCCSmithHG-U133_Plus_2n=177
GSE17536Colorectal cancerDisease Free SurvivalMCCSmithHG-U133_Plus_2n=145
GSE17536Colorectal cancerDisease Specific SurvivalMCCSmithHG-U133_Plus_2n=177
GSE14333Colorectal cancerDisease Free SurvivalMelbourneJorissenHG-U133_Plus_2n=226
GSE17537Colorectal cancerOverall SurvivalVMCSmithHG-U133_Plus_2n=55
GSE17537Colorectal cancerDisease Free SurvivalVMCSmithHG-U133_Plus_2n=55
GSE17537Colorectal cancerDisease Specific SurvivalVMCSmithHG-U133_Plus_2n=49
GSE11595Esophagus cancerAdenocarcinomaOverall SurvivalSuttonGiddingsCRUKDMF_22K_v1.0.0n=34
MGH-gliomaGliomaOverall SurvivalCBTTB, MGH, BWH, CHNuttHG-U95An=50
GSE4412-GPL96GliomaOverall SurvivalUCLA (1996-2003)FreijeHG-U133An=74
GSE4412-GPL97GliomaOverall SurvivalUCLA (1996-2003)FreijeHG-U133Bn=74
GSE4271-GPL96GliomaAstrocytomaOverall SurvivalMDAPhillipsHG-U133An=77
GSE4271-GPL97GliomaAstrocytomaOverall SurvivalMDAPhillipsHG-U133Bn=77
GSE7696GliomaGlioblastomaOverall SurvivalLausanneMuratHG-U133_Plus_2n=70
GSE2837Head and neck cancerSquamous cell carcinomaRecurrence Free SurvivalVUMC, VAMC, UTMDACC (1992-2005)ChungU133_X3Pn=28
jacob-00182-CANDFLung cancerAdenocarcinomaOverall SurvivalCAN/DFSheddenHG-U133An=82
HARVARD-LCLung cancerAdenocarcinomaOverall SurvivalHarvardBeerHG-U95An=84
jacob-00182-HLMLung cancerAdenocarcinomaOverall SurvivalHLMSheddenHG-U133An=79
MICHIGAN-LCLung cancerAdenocarcinomaOverall SurvivalMichigan (1994-2000)BeerHuGeneFLn=86
jacob-00182-MSKLung cancerAdenocarcinomaOverall SurvivalMSKSheddenHG-U133An=104
GSE13213Lung cancerAdenocarcinomaOverall SurvivalNagoya (1995-1999, 2002-2004)TomidaG4112Fn=117
jacob-00182-UMLung cancerAdenocarcinomaOverall SurvivalUMSheddenHG-U133An=178
GSE11117Lung cancerNSCLCOverall SurvivalBasel (2002-2005)BatyNovachip human 34.5kn=41
GSE3141Lung cancerNSCLCOverall SurvivalDukeBildHG-U133_Plus_2n=111
GSE4716-GPL3694Lung cancerNSCLCOverall SurvivalNagoya (1995-1996)TomidaGF200n=50
GSE4716-GPL3696Lung cancerNSCLCOverall SurvivalNagoya (1995-1996)TomidaGF201n=50
GSE8894Lung cancerNSCLCRecurrence Free SurvivalSeoul (1995-2005)LeeHG-U133_Plus_2n=138
GSE4573Lung cancerSquamous cell carcinomaOverall SurvivalMichigan (1991-2002)RaponiHG-U133An=129
GSE9891Ovarian cancerOverall SurvivalAOCS, RBH, WH, NKI-AVL (1992-2006)TothillHG-U133_Plus_2n=278
DUKE-OCOvarian cancerOverall SurvivalDukeBildHG-U133An=133
GSE8841Ovarian cancerOverall SurvivalMilan (1992-2003)MarchiniG4100An=81
GSE17260Ovarian cancerOverall SurvivalNiigata (1997-2008)YoshiharaG4112An=110
GSE17260Ovarian cancerProgression Free SurvivalNiigata (1997-2008)YoshiharaG4112An=110
GSE16560Prostate cancerOverall SurvivalSweden (1977-1999)Sboner6K DASLn=281
E-DKFZ-1Renal cell carcinomaOverall SurvivalRZPDSueltmannA-RZPD-20n=59
GSE19234Skin cancerMelanomaOverall SurvivalNYUBogunovicHG-U133_Plus_2n=38

PrognoScan